November 1, 2023

1. SABPA 2024 Frontiers of Therapeutics and Diagnostics (FTD) Survey 

The SABPA 2024 Frontiers of Therapeutics and Diagnostics (FTD) conference will  be held next year. We will be adding a focus discussion session with different topic  groups in parallel that attendees can select to join. We'd like to hear from you on  your areas of interest and whether you will be interested in inviting subject experts  to join the event. 

Please take a few minutes to finish the survey: 

https://www.surveymonkey.com/r/2024FTD 

SABPA FTD committee 

 

2. Process Chemistry In the Development of KRAS Drugs 

When: Tuesday, November 7, 2023 6:00 PM 

Where: Novartis Institutes for BioMedical Research (10675 John Jay Hopkins  Drive San Diego, CA 92121) 

Please click here for Free registration! 

About the Talk 

This talk will cover the latest developments in the field of KRAS G12C inhibitors.  The first Xiaohu Deng, Ph.D., will present on “Scaleup Efforts on the 

Production of the First-generation, Atropisomeric Covalent KRAS G12C  Inhibitors ARS-1620 and ARS-2102”. The second speaker, Chengyi Chen,  Ph.D., will talk about “Adagrasib (MRTX849) Commercial Route”. Finally, speaker, Haiming Zhang, Ph.D., will discuss the “Development of an  Atroposelective Process of KRAS G12C Inhibitor GDC-6036”. 

About the Speakers 

Dr. Xiaohu Deng -Former Head of CMC at Wellspring Biosciences more info.

Dr. Cheng Yi Chen - VP of Chemistry Process R&D at Mirati more info.

Dr. Haiming Zhang - Distinguished Scientist and Director at Genentech more info.

Program 

4:00-5:00 pm Networking and light dinner 

5:00-5:10 pm General introduction and quick overview of ACS SD & SABPA 5:10-5:15 pm Welcome speech by NIBR San Diego (Venue provider) 5:15-5:30 pm Overview of Medicilon 

5:30-6:00 pm Xiaohu Deng, Ph.D., “Scaleup Efforts on the Production of the First generation, Atropisomeric Covalent KRAS G12C Inhibitors ARS-1620 and ARS 2102” 

6:00-6:30 pm Cheng Yi Chen, Ph.D., “Adagrasib (MRTX849) Commercial Route” 6:30-7:00 pm Haiming Zhang, Ph.D., “Development of an Atroposelective Process  of KRAS G12C Inhibitor GDC-6036” 

7:00-7:55 pm Q&A 

7:55-8:00 pm Closing remarks

 

 

 

3. 2023 mAb Talk symposium----AntibodyPlus Meets AI 

Artificial intelligence technology has expanding applications in many fields,  including antibody discovery/engineering, development, and manufacturing. To facilitate a more in-depth exploration of the next generation of antibody  therapeutics development within the scope of AntibodyPlus and the application of  AI in antibody R&D, the Chinese Antibody Society and its official journal, Antibody Therapeutics will co-host the AbTalk Symposium on the day following the 2023  Antibody Engineering & Therapeutics conference at the same location. 

Registration for the 2023 mAbTalk Symposium of the Chinese Antibody Society is  now open. This event is free of charge and exclusive to all members of the  Chinese Antibody Society. If you are not yet a member of the Chinese Antibody  Society and would like to attend this event, you are welcome to register online to  become a member of our society. 

Event Location: Marriott Marquis San Diego Marina, 333 W Harbor Dr, San  Diego, CA 92101 

Time: December 17, 2023, 10:00 AM-2:00 PM, PST (local time)

Free for CAS members! 

Please click here for registration. 

Due to limited venue capacity, this event will operate on a first-come, first-served  basis. We encourage everyone to register as early as possible. Once we reach the  maximum capacity, event registration will be automatically closed. If you need to  withdraw your registration from the event, please notify our society through email  at conference@chineseantibody.org no later than December 7, 2023.